Ahmadi Z H, Shafaghi Sh, Mandegar M H, Salehi M, Sharif Kashani B, Naghashzadeh F, Jahangirifard A, Bakhshandeh A, Afshar A, Kazempour M, Sheikhan F
Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Cardiac Surgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Int J Organ Transplant Med. 2021;12(3):23-29.
Heart transplantation is an established treatment for end-stage heart failure patients, but its cost-effectiveness is under question.
This study aimed to assess the cost of heart transplantation in Iran as a developing country in Asia to contribute to future planning in the region.
This study was conducted in two phases. First, in a retrospective multicenter study, hospital data of heart transplant and hospitalization of three active heart transplant centers in Tehran, Iran, were reviewed from April 2013 to May 2015. Then pre-transplantation, transplantation, and one-year posttransplant costs were calculated according to the ABC (activity-based costing) method in 2016.
Data were obtained for 120 patients, among which 95 (79.17%) were males with a mean (SD) age of 35.31±13.41 years. Mean (SD) hospital and ICU length of stay were 17.85±14.91 and 9.74±8.94 days, respectively. A significant correlation existed between the mean of hospital and ICU length of stay (P<0.001, r: 0.754). The mean heart transplant and hospitalization cost was 3445.47±1243.29 USD from 2013 to 2015. Using the activity-based costing method, the cost of pre-transplantation, transplantation, and one-year -post-transplantation were extracted 6.5%, 73.5%, and 20%, respectively, with a total cost of 26232 USD.
Compared to other countries, the cost of heart transplantation in Iran is very low. Numerous reasons lead to this difference. Firstly, a heart transplantation surgery is performed in university-based hospitals and is supported by the government. On the other hand, a significant difference exists between personnel costs in Iran compared to other countries.
心脏移植是终末期心力衰竭患者的既定治疗方法，但其成本效益受到质疑。
本研究旨在评估作为亚洲发展中国家的伊朗心脏移植的成本，以为该地区未来规划提供参考。
本研究分两个阶段进行。首先，在一项回顾性多中心研究中，回顾了2013年4月至2015年5月伊朗德黑兰三个活跃心脏移植中心的心脏移植和住院医院数据。然后在2016年根据作业成本法计算移植前、移植和移植后一年的成本。
获取了120例患者的数据，其中95例（79.17%）为男性，平均（标准差）年龄为35.31±13.41岁。平均（标准差）住院时间和重症监护病房住院时间分别为17.85±14.91天和9.74±8.94天。住院时间和重症监护病房住院时间的平均值之间存在显著相关性（P<0.001，r：0.754）。2013年至2015年心脏移植和住院的平均成本为3445.47±1243.29美元。使用作业成本法，移植前、移植和移植后一年的成本分别为6.5%、73.5%和20%，总成本为26232美元。
与其他国家相比，伊朗心脏移植的成本非常低。导致这种差异的原因有很多。首先，心脏移植手术在大学附属医院进行，并得到政府支持。另一方面，伊朗与其他国家相比，人员成本存在显著差异。
